glp-1 receptor agonist pancreatitis risk meta-analysis Why Does Cause Pancreatitis? Factors Explained Glucagon-like peptide-1 receptor agonists and

Despite this, the analysis did not find a statistically significant link between GLP-1 RAs and specific thyroid cancer subtypes, such as papillary or medullary thyroid cancer [134]

Advances in the understanding of headache in idiopathic intracranial hypertension

Whilst diarrhea occurs in up to 20% of patients treated with GLP-1RA, 118 national registry studies from Denmark, 89 Israel, 92 and the USA, 93 collectively involving over 10 000 patients with IBD, found no indication that GLP-1RA use was associated with worsening of IBD symptoms or increased adverse event rates

Approximately 90% of GLP-1 is metabolized by DPP-4 before reaching the central venous circulation (Holst and Deacon, 2005), and the peak circulating concentration of active GLP-1 (7-36)NH 2 after a meal in healthy subjects is usually less than 10 pmol/L due to the rapid degradation of DPP-4 ( In order to solve the problem of rapid inactivation of GLP-1 by DPP-4 degradation, GLP-1RAs and DPP-4 inhibitors have been developed to treat T2DM (Kim and Jang, 2015

Doctors worry about the slow stomach emptying from GLP-1 medications and its effect on aspiration during anesthesia

Short-acting agents like exenatide often cause more gastroparesis (slow gastric emptying), while long-acting ones like dulaglutide may be better tolerated